Real-time enrollment status for this absence epilepsy clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 6:15 AM UTC
| NCT Number | NCT04666610 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Absence Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 12 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | March 13, 2026 (Mar 13, 2026) |
As of April 17, 2026: Clinical trial NCT04666610 is currently active_not_recruiting participants. This clinical trial study for absence epilepsy is not currently accepting new participants at 12 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04666610 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04666610 was last updated Mar 13, 2026 (March 13, 2026). HelloStudys verifies this status automatically.